| DISEASES OF THE PANCREAS - CLINICAL FINDINGS | ||||||||
| Pancreatic Disease | Symptoms | Signs | Abnormal Lab Test Results | Abnormal Imaging Findings | Initial Treatment | General and Follow-Up Treatment | Age Range(s) Typically Found | Prognosis |
| Acute Pancreatitis | Severe epigastric pain radiating to back, nausea, vomiting | Epigastric tenderness, Cullen’s sign, Grey Turner’s sign | ↑Amylase, ↑Lipase, leukocytosis, ↑CRP, abnormal LFTs | Enlarged, inflamed pancreas, peripancreatic fluid collection | IV fluids, pain control, NPO, supportive care | Avoid alcohol, low-fat diet, manage underlying cause | Middle-aged to older adults, younger in gallstone-related cases | Good if mild, severe cases can be life-threatening |
| Chronic Pancreatitis | Chronic abdominal pain, steatorrhea, weight loss | Epigastric tenderness, malnutrition, diabetes | Mildly ↑Amylase, ↑Lipase, low fecal elastase, diabetes | Pancreatic atrophy, calcifications, ductal dilatation | Pain management, pancreatic enzyme supplements, low-fat diet | Avoid alcohol, pancreatic enzyme replacement, diabetes management | Middle-aged to older adults, younger in hereditary cases | Progressive disease with risk of diabetes and malnutrition |
| Diabetes Mellitus Type 1 | Polyuria, polydipsia, weight loss, fatigue | Dehydration, tachycardia, weight loss | ↓Insulin, ↑Glucose, ↑HbA1c, autoantibodies (GAD, IA-2) | No pancreatic abnormalities, atrophy in late stage | Insulin therapy | Lifelong insulin therapy, monitor for complications | Childhood, early adulthood | Lifelong management needed, risk of complications |
| Diabetes Mellitus Type 2 | Polyuria, polydipsia, fatigue, blurred vision | Obesity, acanthosis nigricans, hypertension | ↑Glucose, ↑HbA1c, insulin resistance markers | No pancreatic abnormalities, pancreatic fat deposition in obesity | Lifestyle modification, oral hypoglycemics, insulin if needed | Glycemic control monitoring, weight management, cardiovascular risk reduction | Middle-aged to older adults, rising in younger populations | Variable; controlled with lifestyle and medication, can worsen |
| Pancreatic Insufficiency | Fatty stools, weight loss, bloating, malnutrition | Malnutrition, bloating, vitamin deficiencies | ↓Fecal elastase, abnormal secretin stimulation test | Pancreatic atrophy, malabsorption findings on imaging | Pancreatic enzyme replacement, dietary modification | Monitor nutritional status, adjust enzyme dosage as needed | Any age, more common in chronic pancreatitis or cystic fibrosis | Good with enzyme replacement, poor if untreated |
| Diabetes Mellitus Type 1 | Polyuria, polydipsia, weight loss, fatigue | Dehydration, tachycardia, weight loss | ↓Insulin, ↑Glucose, ↑HbA1c, autoantibodies (GAD, IA-2) | No pancreatic abnormalities, atrophy in late stage | Insulin therapy | Lifelong insulin therapy, monitor for complications | Childhood, early adulthood | Lifelong management needed, risk of complications |
| Diabetes Mellitus Type 2 | Polyuria, polydipsia, fatigue, blurred vision | Obesity, acanthosis nigricans, hypertension | ↑Glucose, ↑HbA1c, insulin resistance markers | No pancreatic abnormalities, pancreatic fat deposition in obesity | Lifestyle modification, oral hypoglycemics, insulin if needed | Glycemic control monitoring, weight management, cardiovascular risk reduction | Middle-aged to older adults, rising in younger populations | Variable; controlled with lifestyle and medication, can worsen |
| Pancreatic Insufficiency | Fatty stools, weight loss, bloating, malnutrition | Malnutrition, bloating, vitamin deficiencies | ↓Fecal elastase, abnormal secretin stimulation test | Pancreatic atrophy, malabsorption findings on imaging | Pancreatic enzyme replacement, dietary modification | Monitor nutritional status, adjust enzyme dosage as needed | Any age, more common in chronic pancreatitis or cystic fibrosis | Good with enzyme replacement, poor if untreated |